The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Peer reviewed, Journal article
MetadataVis full innførsel
OriginalversjonThe Lancet Oncology. 2021, . https://doi.org/10.1016/S1470-2045(21)00581-7
Background: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15–39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods: Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15–39 years to define adolescents and young adults. Findings: There were 1·19 million (95% UI 1·11–1·28) incident cancer cases and 396000 (370000–425 000) deaths due to cancer among people aged 15–39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59·6 [54·5–65·7] per 100 000 person-years) and high-middle SDI countries (53·2 [48·8–57·9] per 100000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14·2 [12·9–15·6] per 100000 person-years) and middle SDI (13·6 [12·6–14·8] per 100000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23·5 million (21·9–25·2) DALYs to the global burden of disease, of which 2·7% (1·9–3·6) came from YLDs and 97·3% (96·4–98·1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation: Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts.
SerieThe Lancet Oncology;Volume 23, Issue 1
TidsskriftThe Lancet Oncology
Opphavsrett© 2021 The Author(s)
Viser innførsler beslektet ved tittel, forfatter og emneord.
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 Sharma, Rajesh; Abbasi-Kangevari, Mohsen; Kisa, Adnan; Vos, Theo; Naghavi, Mohsen; Kisa, Sezer; Colorectal Cancer Collaborator, GBD 2019 (The Lancet Gastroenterology and Hepatology;Volume 7, Issue 7, Peer reviewed; Journal article, 2022-06-13)Background: Colorectal cancer is the third leading cause of cancer deaths worldwide. Given the recent increasing trends in colorectal cancer incidence globally, up-to-date information on the colorectal cancer burden could ...
Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer Kiselev, Yury; Andersen, Sigve; Johannessen, Charles; Fjukstad, Bjørn; Olsen, Karina Standahl; Stenvold, Helge; Al-Saad, Samer; Dønnem, Tom; Richardsen, Elin; Bremnes, Roy M.; Busund, Lill-Tove (Scientific Reports;Volume 8, Article number: 5059 (2018), Journal article; Peer reviewed, 2018-03-22)Lung cancer is the leading cause of cancer deaths. Novel predictive biomarkers are needed to improve treatment selection and more accurate prognostication. PAX6 is a transcription factor with a proposed tumour suppressor ...
“A limited focus on cancer rehabilitation”—A qualitative study of the experiences from Norwegian Cancer Coordinators in Primary Health Care Lie, Nataskja-Elena Kersting; Koren Solvang, Per; Hauken, May (European Journal of Cancer Care; Volume 28, Issue 4. Special Issue: Themed section on Re‐imagining Psycho‐Oncology. July 2019 e13030., Journal article; Peer reviewed, 2019-01-17)Objective: The facilitation of complex cancer rehabilitation interventions in primary health care has become of growing importance to meet the bio-psycho-social needs of cancer survivors. However, the delivery of cancer ...